Roles and regulation of stat family transcription factors in human breast cancer.
about
Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer modelPIKE-A is required for prolactin-mediated STAT5a activation in mammary gland developmentSuppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancerThe Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAsp53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer.STAT3 can be activated through paracrine signaling in breast epithelial cells.Rapid on-membrane proteolytic cleavage for Edman sequencing and mass spectrometric identification of proteins.HMGN2 inducibly binds a novel transactivation domain in nuclear PRLr to coordinate Stat5a-mediated transcription.A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo.CanProVar: a human cancer proteome variation database.C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts.Genome-wide analysis reveals PADI4 cooperates with Elk-1 to activate c-Fos expression in breast cancer cells.Expression of STAT5, COX-2 and PIAS3 in correlation with NSCLC histhopathological features.Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor ModelPTP1B suppresses prolactin activation of Stat5 in breast cancer cells.Cancer chemoprevention: scientific promise, clinical uncertainty.REACTIN: regulatory activity inference of transcription factors underlying human diseases with application to breast cancer.Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cellsAkt is required for Stat5 activation and mammary differentiation.Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformationTrefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma.Identification of a STAT5 target gene, Dpf3, provides novel insights in chronic lymphocytic leukemia.Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.Increased STAT1 signaling in endocrine-resistant breast cancer.Signal transducers and activators of transcription-3 up-regulates tissue inhibitor of metalloproteinase-1 expression and decreases invasiveness of breast cancer.STAT3 and STAT5b polymorphism contributes to breast cancer risk and clinical outcomes.Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activityCell Surface GRP78 Accelerated Breast Cancer Cell Proliferation and Migration by Activating STAT3.STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferationMUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cellsStat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer.Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-ĸB signaling, and synergizes with an ERK inhibitorA novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells.Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signallingCharacterization of transcription factor response kinetics in parallel.Seasonal Expression of Prolactin Receptor in the Scented Gland of Male Muskrat (Ondatra zibethicus).Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia
P2860
Q21090788-223F5398-CF6A-41C1-9B25-ADE209150FDAQ24295182-0A5564FD-73A6-44C8-9B6F-0F5BFD1508B6Q24677026-98F476D4-8B0F-4396-825E-6FA4B05604B6Q26801471-5EAE2E15-CA76-47DF-84E9-7F8FA969322AQ27851827-A17FEA98-E501-4A9B-A8FF-E44875BF0023Q30849602-45774110-B0BF-4D3E-BBA8-663350A9D09EQ33225677-8FFF1EFD-9440-4C06-821D-34C52991F479Q33636880-3499986B-5810-4CAA-9819-43E5B1356313Q33642635-E246B7AA-8021-4B81-A082-62BBA8701194Q33691397-85A42C42-439B-4949-A7C8-B3712236EF51Q33827026-96D7DE85-AE63-4CD0-8BE5-6BAAEB71B55EQ33829474-566D2CE9-36C5-481F-AEFB-26F627451040Q33843535-E333AC7B-FD04-4C88-9248-351CB210A843Q33926858-7596ABF5-9647-45D3-8AC4-8E23B451B45AQ34066293-9DB439B6-77B6-4F17-896E-FBC242139246Q34343680-6B8E372C-E00C-490F-B297-0C03F3072A0AQ34358316-FE3AF53D-F953-48B6-9D6C-B00BB6BE51A6Q34456971-D72BB331-0D3D-482C-86CD-EA84C30FDB38Q34865218-9D506640-3FD5-4B30-A043-BBAAEF9B102FQ34978267-9FBCAAE1-2999-41BC-8EBD-44C0F85BF159Q34989027-01DB56C7-EF0B-486E-A938-73139FDBCE1EQ34989115-50B83E33-774B-4264-B792-ED35F00B63DBQ35000231-BAEAFDCD-76E8-4B6D-8242-E245D2F61400Q35025251-8E4596A4-C239-4954-B737-AECD153729DCQ35127916-84F2B985-2EE5-4164-BE36-C7A0439183BDQ35146693-8992B24F-DE77-4756-BB75-7801DAA6333CQ35221996-F84BB2EC-8EB3-47BA-AA49-4B7DE9EE4815Q35405293-4913F3BD-2355-4DFB-AB90-ABDD49D9E5D4Q35558119-F6EBC84A-5D97-4E5B-AD31-D595A33D37C7Q35583247-48CC1534-8C71-4B08-B6E1-80A4659BC769Q35606710-92906E7F-20D8-4B92-A4C1-8545ADC52FFCQ35770784-EED7C064-99B7-4E99-8576-AA2322A62D82Q35784718-32AD7154-BF6B-4AA9-AD5A-82FA6A980554Q35906313-71B8447E-8419-4FA9-87DE-400C54F07AEEQ35925413-9CB1880E-6FC2-4DE2-B02C-842F9E00FBDAQ35931759-11691E29-D7C5-47A4-B9C2-AF321C512B26Q36053060-CB6CE1B5-BED0-45EB-817E-06675F614A88Q36111936-FF66C037-FE55-41DA-A713-DC8920CF5CB5Q36174582-DC7C9A5D-A689-4D1B-A949-E5C43163F0EEQ36238674-EAA91DD8-63BD-4110-B1CB-C6C37B39102A
P2860
Roles and regulation of stat family transcription factors in human breast cancer.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Roles and regulation of stat family transcription factors in human breast cancer.
@ast
Roles and regulation of stat family transcription factors in human breast cancer.
@en
type
label
Roles and regulation of stat family transcription factors in human breast cancer.
@ast
Roles and regulation of stat family transcription factors in human breast cancer.
@en
prefLabel
Roles and regulation of stat family transcription factors in human breast cancer.
@ast
Roles and regulation of stat family transcription factors in human breast cancer.
@en
P2860
P1476
Roles and regulation of stat family transcription factors in human breast cancer.
@en
P2093
Charles V Clevenger
P2860
P304
P356
10.1016/S0002-9440(10)63403-7
P407
P577
2004-11-01T00:00:00Z